December 1-4, 2026 | Las Vegas Convention Center

Q

Beyond THC and CBD: The Science and Commerce of Minor Cannabinoids

The race to the highest THC percentage is losing steam. Educated buyers now ask what a product does, not just how strong it is, and that shift is rewriting cannabis market trends across cultivation, retail, and manufacturing. Minor cannabinoids sit at the center of...

Mind, Molecule, Market: Cannabis and Psychedelics in Mental Health

Mental health treatment is shifting fast, and two once-taboo categories now sit at the center of it. Cannabis and psychedelics are moving from the margins toward clinical legitimacy, with mounting evidence supporting their use for anxiety, depression, PTSD, and...